NCT07013188Recruiting
Characterising the Neuromuscular Function of Post Stroke Patients
Characterising the Neuromuscular Function of Stroke Patients During Recovery
Source: ClinicalTrials.gov · Last updated 10 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Strokes are a leading cause of death and disability in developed countries, with significant economic and social impacts. Defined by the WHO, strokes cause rapid and lasting disturbances in cerebral function. In the UK, strokes occur every five minutes, affecting 100,000 people annually and resulting in substantial physical impairments and financial costs. Although stroke-related deaths have decreased due to improved treatments and awareness, strokes remain a major cause of death and disability worldwide, especially in lower-income countries. Strokes typically cause unilateral deficits, leading to significant daily challenges and necessitating tailored rehabilitation strategies such as CIMT, FES, and VR Rehab. As the population ages, innovative neurorehabilitation approaches are essential to enhance functional recovery post-stroke. This pilot study aims to better understand the neuromuscular deficits caused by stroke to inform and improve future rehabilitation interventions, including the potential use of force accuracy training (FAT)
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 16 (estimated)
- First submitted
- 27 Sept 2024
- Start date
- 1 Jun 2024
- Primary completion date
- 1 Oct 2025
- Lead sponsor
- University of Nottingham
- Diseases
- Stroke
- NCT number
- NCT07013188
What you commit to
- Study type: Observational
- Planned participants: 16
- From 1 Jun 2024 to the primary completion date, 1 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Diagnosis of cognitive impairment/dementia
- Current or recent (\<2y) malignancy
- Severe respiratory disease (e.g., uncontrolled asthma, COPD, pulmonary hypertension)
- Active cardiovascular disease: Uncontrolled hypertension (BP\>160/100mmHg); Recent (\<12mo) cardiac event; Heart failure (Class III/IV); Significant arrhythmia; Unstable angina
- Metabolic disease: Untreated hyper/hypoparathyroidism; Cushing's disease
- Significant musculoskeletal disorders (based on clinical opinion)
- Dialysis patients
- Recent steroid treatment within 6 months or hormone replacement therapy
- Mobility dependant (wheelchair dependency)
Who the study is looking for
- • Aged between 40-85 years
- Willing and able to give informed consent for participation in the study
- Had a confirmed stroke within the last 5 years
- Self-reports persisting post-stroke loss of unilateral limb function
Age in the registry: 40 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal Derby Hospital branch, School of Medicine, University of Nottingham Coordinator of this site? Confirm its status | Derby | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.